Mangoceuticals, Other Non Cash Items from 2010 to 2024

MGRX Stock   2.50  0.03  1.19%   
Mangoceuticals, Common Other Non Cash Items yearly trend continues to be fairly stable with very little volatility. Other Non Cash Items is likely to outpace its year average in 2024. During the period from 2010 to 2024, Mangoceuticals, Common Other Non Cash Items regression line of annual values had r-squared of  0.44 and arithmetic mean of  244,885. View All Fundamentals
 
Other Non Cash Items  
First Reported
2010-12-31
Previous Quarter
1.5 M
Current Value
1.6 M
Quarterly Volatility
553.1 K
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Mangoceuticals, Common financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Mangoceuticals, Common's main balance sheet or income statement drivers, such as Depreciation And Amortization of 26.4 K, Interest Expense of 0.0 or Selling General Administrative of 6.8 M, as well as many indicators such as Price To Sales Ratio of 7.7, Dividend Yield of 0.0 or PTB Ratio of 8.03. Mangoceuticals, financial statements analysis is a perfect complement when working with Mangoceuticals, Common Valuation or Volatility modules.
  
Check out the analysis of Mangoceuticals, Common Correlation against competitors.

Latest Mangoceuticals, Common's Other Non Cash Items Growth Pattern

Below is the plot of the Other Non Cash Items of Mangoceuticals, Common Stock over the last few years. It is Mangoceuticals, Common's Other Non Cash Items historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Mangoceuticals, Common's overall financial position and show how it may be relating to other accounts over time.
Other Non Cash Items10 Years Trend
Slightly volatile
   Other Non Cash Items   
       Timeline  

Mangoceuticals, Other Non Cash Items Regression Statistics

Arithmetic Mean244,885
Geometric Mean1,034
Coefficient Of Variation225.88
Mean Deviation391,526
Median181.00
Standard Deviation553,142
Sample Variance306B
Range1.6M
R-Value0.67
Mean Square Error183.2B
R-Squared0.44
Significance0.01
Slope82,419
Total Sum of Squares4.3T

Mangoceuticals, Other Non Cash Items History

20241.6 M
20231.5 M
2022546.5 K

About Mangoceuticals, Common Financial Statements

Mangoceuticals, Common investors use historical fundamental indicators, such as Mangoceuticals, Common's Other Non Cash Items, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Mangoceuticals, Common. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Other Non Cash Items1.5 M1.6 M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Mangoceuticals, Stock Analysis

When running Mangoceuticals, Common's price analysis, check to measure Mangoceuticals, Common's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Mangoceuticals, Common is operating at the current time. Most of Mangoceuticals, Common's value examination focuses on studying past and present price action to predict the probability of Mangoceuticals, Common's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Mangoceuticals, Common's price. Additionally, you may evaluate how the addition of Mangoceuticals, Common to your portfolios can decrease your overall portfolio volatility.